RFID Smart Cabinets Market to Register 12% CAGR till 2020

The global RFID Smart Cabinets Market is expected to grow at a nearly 12% CAGR during the forecast period (2012 to 2020). The industry is poised to reach around USD 785 million by 2020. In healthcare, RFID (radio-frequency identification) is applied widely in equipment tracking and in record maintenance. Cost cutting measures adopted by healthcare institutions for effective inventory management drive demand for RFID smart cabinets. These cabinets are made of two components, namely, RFID console and a steel/aluminum cabinet. The cabinet is used for maintaining databases, like identity of the person or department that accessed it recently and the date of last usage. RFID console is an electronic part that helps keep a track on cabinet supplies. Surging demand for RFID cabinets for inventory management and technological advancements are expected to positively impact the global market throughout the forecast period.

The worldwide RFID Smart Cabinets Market is segmented into geographies, namely Latin America, North America, Asia Pacific, Europe, and Rest of the World. Most healthcare institutions in North America have begun using RFID cabinets for enhanced productivity and minimal errors. The region is propelled by huge product demand from the U.S. Sophisticated healthcare infrastructure and steady technological developments are two key factors that drive the North America market. This region may continue leading the global industry till 2020.

Browse Details of Report @ https://www.hexaresearch.com/research-report/rfid-smart-cabinets-industry

In the U.K. and Germany, huge funds are injected into the healthcare sectors by both governmental organizations and NGOs. Germany dominates the Europe RFID cabinets market owing to high R&D investments in RFID applications. With focus on RFID technologies, the government of Germany had invested around USD 260 million in the year 2007. Furthermore, the country declared that technological developments fuel applications of RFID technologies not only in the healthcare sector but also in its telecommunications industry. The need for effective inventory management strategies and the prevention of pilferage of assets & inventories can fuel the global industry during the forecast period.

Owing to surging demand from India and China, Asia Pacific is expected to be a rapidly growing region from 2012 to 2020. Furthermore, technological developments and improvements in healthcare infrastructure in China and India could effectively contribute to regional progress. Execution of the 12 year plan in China may lead manufacturers to invest robustly in the region. Favorable governmental regulations, the expanding telecommunications sector, and widespread awareness among patients are factors that drive the RFID industry in India. Proliferation of retail stores selling products with RFID tags can positively impact the overall industry during the forecast period.

Prominent industry participants are Tagsys RFID Group; Stanley Innerspace; LogTag; Mobile Aspects Inc.; and Terson Solutions Inc. among others. The global RFID smart cabinets market is a highly fragmented one with a large pool of suppliers and a host of domestic manufacturers in China. Mergers and acquisitions are key business expansion strategies adopted by several companies. In February 2016, Nordic ID launched the Nordic ID AR52 area reader. It is a fixed reader that is equipped with sixteen external antenna ports. It is the centre point for connecting the antennas that can be adjusted and controlled individually.

Browse Related Category Report @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com

Electromedical and X-ray Equipment Market Size and Share Report, 2024

22 March 2019, X-beam is a kind of electromagnetic ionizing radiation with applications in a broadened scope of businesses. In therapeutic industry, X-beam gadgets constitute the biggest offer of the symptomatic imaging market. The maturing of the world's population and the rising occurrence of growth, coronary illness, and different conditions is driving the demand for Electromedical And X-Ray Equipment Market for cancer, heart disease, and X-rat gadgets. Interest is driven by mechanical progressions, demographics (the maturing US populace drives the requirement for medicinal items), and the necessities of the human services industry. The profitability of individual organizations relies on upon operations and viable advertising. Vast organizations appreciate economies of scale in examination, assembling, advertising, and conveyance. Littler organizations can contend adequately by creating inventive advancements or claim to fame items for corner markets, for example, growth treatment device.

Accessibility of substantial number of players in the business sector has led to a nonstop evolvement of cutting edge advances to build image quality. Advanced imaging procedures keep on evolving with enhancements in picture quality, measurement lessening systems, and efficiencies in work process. The X-ray gadgets innovation has moved from simple imaging to advance. X-rays show numerous applications in the diagnostic as well as therapeutic areas of cancer, cardiovascular and mid-section illnesses to give some examples. Fast advances in radiology that have happened in the previous couple of decades have made ready for the extension of the medicinal imaging hardware market. Imaging gadgets, for example, magnetic resonance imaging (MRI), computed tomography (CT or CAT), and ultrasound have permitted further choices for treatment direction with low dismalness. This has helped doctors to evaluate patients without surgical mediation and along these lines enhance the patient results and personal satisfaction

Browse Details of Report @ https://www.hexaresearch.com/research-report/electromedical-x-ray-equipment-market

X-ray imaging gadgets constituted the key fragmenst in the worldwide medical imaging equipment market. The key driving forces for the development of this segment includes expanding occurrence of scatters and simple accessibility and adequacy of x-ray gadgets. Rising occurrence of cardiovascular, respiratory, oral, gastrointestinal, and genitourinary scatters are boosting dependence on a few propelled x-beam indicative gadgets all around. The WHO gauges that around 60% to 90% of school kids and 80% to 90% grown-ups (matured 19 to 34 years) experience the ill effects of dental cavities. In addition, the worldwide rate of oral growth ranges between 1-10 cases for every 100,000 people. These two variables, combined with an expansive patient pool of patients experiencing dental pits, is expected to boost the industry growth. Among the x-ray gadgets market, stationary gadgets overwhelmed the business sector by ideals of being routinely utilized imaging gadgets. These are likewise a more financially savvy choice contrasted with compact x-beam hardware gadgets. Stationary gadgets are for the most part favored in the underserved markets of Asia and Africa.

Based on product type, the Electromedical and X-ray Equipment Market is segmented into Digital Radiography (DR), Computed Radiography (CR) and retrofit radiography system. Electro-medical equipment includes a variety of powered devices, such as pacemakers, patient-monitoring systems, MRI machines, diagnostic imaging equipment (including informatics equipment), and ultrasonic scanning devices.

Established markets such as the US, Western Europe, and Japan are top sales regions for the industry. Developing nations such as Brazil, Russia, India, and China are targeted by companies in the industry for growth.

Major US companies include Medtronic,Hologic, Varian Medical Systems,, St Jude Medical and ZollMedical, as well as  General Electric. Outside the US, major companies includeSonova (Switzerland), St Jude Medical,, St Jude Medical., Bracco Imaging S.p.A, , Agfa-Gevaert N.V ,Canon, Inc., Fujifilm Holdings Corporation,,Agfa-Gevaert N.V, Hologic, Inc., Hitachi Medical Corporation, Konica Minolta, Inc., Shimadzu Corporation,, Agfa-Gevaert N.V., Philips Healthcare, , Agfa-Gevaert N.V , Thales group,, Agfa-Gevaert N.V, Varian Medical Systems, Inc., , Agfa-Gevaert N.V  and Ziehm Imaging, Inc.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-imaging-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com

Orthobiologics Market Size, Share, Trends and Competition, 2025

13 March 2019, The global Orthobiologics Market is expected to witness strong growth in the years to come due to rising prevalence of musculoskeletal and orthopedic illnesses across the world. Increasing road accidents and sports injuries are likely to increase the product demand in the coming years. In addition, growing geriatric population is a key driving factor in the market as they are more vulnerable to spinal and other orthopedic disorders. This has, in turn, increased the number of orthopedic procedures.

Advancements in implant techniques and rising demand for biological solutions over mechanical solutions are likely to create opportunities for the market. Technological advancements in biomaterials, which are utilized in the production of orthobiologics, are anticipated to support market growth. Such advancements include development of recombinant biologic agents, modifications in graft designs, stem cell therapy, and cultured tissue scaffolds. These innovations are likely to provide benefits, such as smaller incisions, improved biocompatibility, and reduced procedure time. Reduction in post-operative complications using these innovative solutions is expected to boost market growth in the years to come. Furthermore, increasing prevalence of obesity and arthritis, especially in developed countries is expected to boost market growth. This has, in turn, increased the demand for minimally invasive surgeries that generally include bone grafting and growth factor treatments. Orthobiologic therapy is one of the key components of regenerative medicine that are used to treat musculoskeletal diseases, including degenerative osteoarthritis. It is one of the important treatment options for early osteoarthritis (OA) of the knee.

However, strict regulatory framework regarding approval of orthobiologics and high cost of these products are anticipated to challenge the market.

Browse Details of Report @ https://www.hexaresearch.com/research-report/orthobiologics-market

Orthobiologics include a wide range of products, such as bone matrix (DBM), allograft, synthetic bone substitutes, bone morphogenetic protein (BMP), stem cell therapy, and viscosupplementation. Viscosupplementation holds a prominent share in the market due to its high adoption in diseases, such as hip degenerative joint disease and osteoarthritis. Benefits, including fewer side effects, pain reduction, better knee movement, and less-invasive nature, are likely to boost the product’s demand. Moreover, increasing popularity of minimally invasive surgeries is anticipated to boost the segment’s growth in the coming years. Orthobiologics are extensively used in applications, such as spinal fusion, trauma repair, and reconstructive surgery. Spinal fusion is a leading application in the market due to increasing use of demineralized bone matrices, bone morphogenetic proteins, and autografts and allografts in spinal fusion surgeries. This could be attributed to its ability to speed up the bone healing process and offer high bone stability, facilitating long-term improvement of spinal disorders. It also offers fast stimulation of cells to enable bone formation and avoids hospital stays and repetitive visits. Key end users of orthobiologics include hospitals and orthopedic clinics. Hospital occupies a larger share in the market than clinics due to increasing use of orthobiological products in various spinal and reconstructive surgeries conducted in hospitals.

North America is one of the leading regional markets due to presence of key players involved in undertaking new product development strategies. In addition, availability of better compensation policies for soft tissue healing and fusion improvement products is boosting regional market growth.

Asia Pacific is projected to witness strong growth in the years to come owing to rising healthcare expenditure and improving economic conditions. Additionally, increasing awareness regarding availability of these products among physicians is likely to increase their sales. Frequent product launch and improvement in healthcare infrastructure are also projected to offer remunerative gains in the years to come.

Some of the key players operating in the orthobiologics market are DePuy Synthes, Inc.; Medtronic; Stryker Corporation; Genzyme; and Smith & Nephew plc. Players are increasingly investing in R&D activities and taking up strategies, such as mergers and acquisitions, to gain a competitive edge in the market. Moreover, increasing collaborations between biotechnology and medical device companies for the development of effective orthobiologics is expected to support market growth.

For instance, BONESUPPORT, a prominent company in orthobiologics for the management of bone voids, announced that it has started selling CERAMENT BVF through its own US distributor network. Similarly, Cesca Therapeutics Inc. announced that its subsidiary named ThermoGenesis, introduced its PXP System. The system offers fast processing of autologous bone marrow cells in the point-of-care (POC) setting.

Browse Related Category Market Reports@ https://www.hexaresearch.com/research-category/healthcare-industry

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com

Kidney Cancer Drugs Market is Projected to Grow at a Healthy CAGR till 2025

The global Kidney Cancer Drugs Market is expected to grow at a healthy rate during the forecast period. Renal Cell Carcinoma (RCC) is one of the most common types of urologic tumors in adults. It accounts for around 2% of all new cases of tumor in humans. However, clinical removal of the cancerous cells is vital for a total cure from the disease. Until last few decades, surgical removal of kidneys. This treatment method was later replaced by laparoscopic removal of tumor-affected area. Medicines are generally prescribed to cure tumors at advanced stage of disease progression.

Early diagnosis is vital when it comes to treatment of this disease. Various treatment methods such as immune modulation therapy, Vascular Endothelial Growth Factor (VEGF) inhibitors, and cytokine therapy are utilized to cure the tumor. Additionally, variety of drugs are available for the treatment of diseases like kidney cancer when identified at an early stage. Hence, governments and healthcare organizations are engaging in awareness drives for early detection. This factor is anticipated to bode well for market over the forecast period.

Prevalence of RCC is projected to increase in near future owing to factors such as rising obesity and number of smokers and reduced physical activities due to changing lifestyle. Symptoms of renal cancer are similar to several other kidney disorders, which make it difficult to get detected. This factor also reduces survival rate among patients who are mostly diagnosed with RCC during routine checkups for some other medical conditions.

Browse Details of Report @ https://www.hexaresearch.com/research-report/kidney-cancer-drugs-market

The global market is majorly driven by changing lifestyle of the global population. Predominance of lifestyle influenced diseases is one of the major driving factors. Excessive smoking and alcohol consumption lead to chronic diseases including different types of cancer. This factor is expected to fuel the market for kidney cancer medicine in the forthcoming years. Rising geriatric population prone to chronic diseases is projected to propel demand for these medicines in the years to come.

Preference for these drugs over targeted remedies is anticipated to bode well for growth of the global market over the forecast period. Also, availability of a limited number of approved drugs is one of the factors assisting product demand. Kidney cancer medicines are one of the life protracting treatment options available for patients suffering from advanced stage of metastatic tumor. Furthermore, occurrence of this disease is expected to be higher in developed countries compared to developing regions. This factor is expected to impel demand for these medicines from regions like North America and Europe.

However, high price of branded drugs is projected to hinder overall growth over the forecast period. As a result, generic medicine variants are preferred over their branded counterparts. This factor is anticipated to obstruct market development in the forthcoming years.

Primary branded medicines in the global kidney cancer drugs market include Nexavar (Sorafenib), Inlyta (Axitinib), Avastin (Bevacizumab), Votrient (Pazopanib), Afinitor (Everolimus), Sutent (Sunitinib), Torisel (Temsirolimus), and Proleukin (Interlukin-2/Aldesleukin). Sutent was one of the highly demanded medicine types in the past. However, drugs like Votrient are also anticipated to witness substantial demand over the forecast period. At present, most potential drugs are in phase II and III clinical trials. Medicines such as Keytruda, AGS-003, Opdivo, Cabozantinib, and Dovitinib are projected to be commercialized and launched in the years to come.

North America accounted for a prominent market share in the past. High prevalence of kidney cancer and other kidney diseases is the primary growth driver. Additionally, U.S. is the largest market for pharmaceuticals. This factor is anticipated to bode well for the growth of the regional demand for kidney cancer drugs. Asia Pacific is estimated to witness significant growth over the forecast period. Lower cost of drug production, high disease prevalence, and rising awareness among healthcare professionals as well as consumers are projected to drive regional growth in the forthcoming years.
The global market is highly consolidated and displays high competition among key participants. Major pharmaceutical giants in the market include Pfizer Inc.; Bayer Pharma AG; GlaxoSmithKline Plc; Hoffman-La Roche; and Novartis AG. Major companies are capitalizing heavily on research and development and adopting strategies like collaborations, new product launches, business expansions, and innovation to uphold their market share.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

 About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - https://www.hexaresearch.com